FDA Approved: ALVAIZ — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

ALVAIZ (eltrombopag) from Teva received FDA approval through an original application for the treatment of thrombocytopenia conditions by increasing platelet cou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Immune Thrombocytopenia
• Thrombocytopenia

Drugs mentioned

• ALVAIZ (eltrombopag)

Snippet

ORIG AP for ALVAIZ (ELTROMBOPAG)